October 2019 Price Concessions – 1st update

THIS CONTENT HAS NOW EXPIRED

October 2019 Price Concessions – 1st update

October 21, 2019

Department of Health and Social Care (DHSC) has today granted the following initial list of price concessions:

Drug Pack Size Price Concession
Alverine 60mg capsules 100 £9.25
Cyclizine 50mg/1ml solution for injection ampoules 5 £12.61
Hydroxyzine 25mg tablets 28 £0.85
Indapamide 2.5mg tablets 28 £2.48
Irbesartan 150mg tablets 28 £5.57
Mirtazapine 15mg tablets 28 £2.02
Mirtazapine 45mg tablets 28 £1.99
Mometasone 50micrograms/dose nasal spray 140 £4.11
Quinine sulfate 300mg tablets 28 £4.84

No additional endorsements are required for price concessions. A price concession only applies for the month in which it is granted.

PSNC is still working with the DHSC to agree further concessionary prices on other drugs reported to be unavailable at the stated October 2019 Drug Tariff price. Contractors will be alerted to further updates to the price concession list through our website and via our e-news email.  If you wish to subscribe to our email list, you can receive an email as soon as any announcements are made. Please note that PSNC cannot provide details of any generic products awaiting price concession approval from DHSC.

If you have problems obtaining a Part VIII product or problems obtaining the product at the stated Drug Tariff price, please report the issue to PSNC using the online feedback form on the PSNC Website.
Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. PSNC will investigate the extent of the problem and if appropriate discuss the issue with DHSC.



Posted in:


More Latest News >

CPCS Frequently Asked Questions

With the Community Pharmacist Consultation Service (CPCS) now bedding in, below you will find a selection of questions about the...

CPCS: CPD opportunities

As announced in the 5-year CPCF agreement, NHS England & NHS Improvement and Health Education England (HEE) will use funding...